Liquisolid systems to improve the dissolution of Furosemide

Scientia Pharmaceutica

Volumn 78, Issue 2, 2010, Pages 325-344

  Akinlade, Babatunde ^a   Elkordy, Amal A ^a   Essa, Ebtessam A ^b   Elhagar, Sahar ^b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b Tanta University   (Egypt)

Author keywords

Dissolution; Friability; Furosemide; Liquisolid compacts; Synperonic PE L 81

Indexed keywords

9 OCTADECENOATE; AEROSIL; COPOLYMER; DRUG CARRIER; FUROSEMIDE; GLYCEROL; MACROGOL; MACROGOL 400; MELOXICAM; MICROCRYSTALLINE CELLULOSE; POLOXAMER; POLYSORBATE 80; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COATING; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS;

EID: 77954635184     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0912-23     Document Type: Article

References (24)

1. Dressman JB. Drug solubility: how to measure it, how to improve it. Adv Drug Deliv Rev. 2007; 59: 531-532. doi:10.1016/j.addr.2007.05.014.
2. Dressman JB, Horter D. Influence of physiochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 1997; 25: 3-14. doi:10.1016/S0169-409X(96)00487-5
3. Spireas SS, Wang T, Grover R. Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts. Drug Dev Ind Pharm. 1999; 25: 163-168. doi:10.1081/DDC-100102156
4. Spireas S, Bolton SM. Liquisolid Systems and Methods of Preparing Same. U.S. Patent, Patent 1999; 5, 968,550.
5. Javadzadeh Y, Siahi MR, Jalali BM, Nokhodchi A. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Il Farmaco. 2005; 60: 361-365. doi:10.1016/j.farmac.2004.09.005
6. Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from iquisolid compacts. J Pharm Pharm Sci. 2005; 8: 18-25. PMid:15946594
7. Javadzadeh Y, Siahi MR, Asnaashari S. Nokhodchi A. Liquidsolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physiochemical properties. Acta Pharm. 2007; 57: 99-109. doi:10.2478/v10007-007-0008-6
8. Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm. 2009; 73: 373-384. doi:10.1016/j.ejpb.2009.08.002
9. Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm. 2007; 341: 26-34. doi:10.1016/j.ijpharm.2007.03.034
10. Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm. 1998; 166: 177-188. doi:10.1016/S0378-5173(98)00046-5
11. Tayel SA, Soliman II, Louis D. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique. Eur J Pharm Biopharm. 2008; 69: 342-347. doi:10.1016/j.ejpb.2007.09.003
12. Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablets for mulation: In vitro and in vivo evaluation. Eur J Pharm Biopharm. 2008; 69: 993-1003. doi:10.1016/j.ejpb.2008.02.017
13. Abdel-Hamid ME. High-performance liquid chromatography-mass spectrometric analysis of furosemide in plasma and its use in pharmacokinetic studies. Il Farmaco. 2000; 55: 448-454. doi:10.1016/S0014-827X(00)00064-1
14. Jackson EK. Goodman and Gilman's the Pharmacological Basis of therapeutics. McGraw-Hill, New York, 1996.
15. Hammarlund MM, Paalzow LK, Odlind B. Pharamcokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis. Eur J Clin Pharmacol. 1984; 26: 197-207. doi:10.1007/BF00630286
16. El-Gizawy SA. Effect of formulation additives in the dissolution of Meloxicam from Liquid solid tablets. Egypt J Biomed Sci. 2007; 25: 143-158.
17. Lin JC, Wang CY. Effects of surfactant treatment of silver powder on the rheology of its thick-film paste. Mater Chem Phys. 1996; 45: 136-144. doi:10.1016/0254-0584(96)80091-5
18. Wells JI, Aulton ME. Pharmaceutical preformulation. In: Aulton ME (Ed.). Aulton's Pharmaceutics: The Design and Maufacture of Medicines. 3rd ed., Churchill Livingstone, Elsivier limited, UK. 2002; pp: 336-360.
19. British Pharmacopoeia 2008.
20. Ponto LLB, Schoenwald RD. Furosemide (frusemide): a pharmacokinetic/pharmacodynamic review (part I). Clin Pharmacokinet. 1990; 18: 381-408. PMid:2185908
21. Shin S, Oh J, Lee Y, Choi K, Choi J. Enhanced dissolution of furosemide by coprecipitating or cogriding with crospovidone. Int J Pharm. 1998; 175: 17-24. doi:10.1016/S0378-5173(98)00260-9
22. Shin S, Kim J. Physicochemical characterization of solid dispersion of furosemide with TPGS. Int J Pharm. 2003; 251: 79-84. doi:10.1016/S0378-5173(02)00586-0
23. Spireas S. Liquisolid Systems and Methods of Preparing Same. U.S. Patent 2002; 6,423,339 Bl.
24. Carr RL. Evaluation flow properties of solids. Chem Eng. 1965; 72: 163-168.